Every year, millions of children worldwide suffer from diarrhea and are at risk of dehydration. S. boulardii I-3799 has showed beneficial effects in children diarrhea management.
Saccharomyces boulardii uses for adults and children diarrhea management is already recommended by doctors and gastroenterologists for decades and is highly documented in the litterature. A meta-analysis designed to compare various nutritional and pharmacologic interventions in reducing diarrhea duration supports towards the use of saccharomyces boulardii in the management of acute children diarrhea.
Children diarrhea management, a clinically proven efficacy for the unique probiotic yeast S. boulardii I-3799
A recent published clinical study, on 100 infants and children 3-36 months of age, has been conducted to assess the safety and efficacy of our unique probiotic yeast strain S.boulardii I-3799 (marketed as Lynside® Pro SCB) in the management of acute diarrhea in children.
During this study, the children were randomly allocated to the probiotic yeast group (receiving S. boulardii I-3799 at a daily dosage of 5 billion CFU twice daily for 5 days) or to the placebo group.
The administration of the unique probiotic yeast demonstrates beneficial effects on the reduction and severity of diarrhea in infants and children.
The results of this study confirms S. boulardii I-3799 supplementation consistency with the scientific literature on saccharomyces boulardii benefits for digestive health.
S. boulardii I-3799, the premium probiotic yeast offering 5 years shelf life
Probiotic yeasts are today well-known for their formulation advantages : shelf stable probiotic, no need to be refrigerated and also a long shelf life that can generally go up to 3 years.
Aware that the formulation with probiotic strains remains a daily challenge for our customers, we worked with our experts in order to bring them a strain that could answer these problems. This is why we can now offer our probiotic yeast Saccharomyces cerevisiae I-3799 with a 5-year shelf life. This extended shelf life reinforces the uniqueness and technical superiority of our strain, reflecting our 160 years of experience in the field of yeasts.
Representing a real opportunity and optimal flexibility for your future food supplements developments, get in touch with us to ask for more details.
DISCOVER ALL OUR LATEST NEWS
Optimal Folate Intake in Elderly Women May Help Reduce Osteoporosis Risk
Research has shown that up to 20% of bone loss can occur during menopause, making proper health management essential. Dietary choices, regular exercise, and medications can help prevent further bone loss and decrease the risk of fractures.
However, osteoporosis is often known as ‘a silent disease’ and is likely to be determined by the first bone break or a decrease in bone density.
Quatrefolic® can potentially reduce the risk of osteoporosis by normalising homocysteine levels, an amino acid that helps support bone structure.
MenaQ7® Matrix K2: A Perfect Fit in Magnesium Formulations
Our latest stability data shows MenaQ7® Matrix is the perfect choice when combining the essential vitamin— K2—with the essential mineral—Magnesium.
New Quatrefolic® Educational Video
Although folate and folic acid are often used interchangeably, they are not the same thing. It is essential to understand the difference between the two for optimal health.
Quatrefolic® commitment is to educate and share information to promote the advantages of active folate for the human health.
